Quote For Myriad Genetics Inc MYGN.O
Myriad Genetics Inc (MYGN.O) (Nasdaq)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
$23.94
6:19pm GMT
+1.10%
$23.68
$23.57
419,124
$23.97
$23.57
$44.90
$22.38
0.24
1,579,830
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Henderson, John | Chairman of the Board | -- |
| Meldrum, Peter | President, Chief Executive Officer, Director | 4,061,080 |
| Gilbert, Walter | Vice Chairman of the Board | -- |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $2,278.05 |
| Shares Outstanding (Mil.) | 96.20 |
| Float (Mil.) | 94.19 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | 0.00 |
| Financial Strength | |
|---|---|
| Quick Ratio | 11.37 |
| Current Ratio | 19.55 |
| LT Debt/Equity | 0.00 |
| Total Debt/Equity | 0.00 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 16.53 |
| Price/Sales(TTM) | 6.67 |
| Price/Book(TTM) | 4.81 |
| Price/Cash Flow(TTM) | 15.07 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $1.50 |
| Sales(TTM) | $3.44 |
| Book Value(MRQ) | $4.92 |
| Cash Flow(TTM) | $1.52 |
| Cash(MRQ) | $3.72 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 29.92 |
| Return on Assets(TTM) | 27.73 |
| Return on Investment(TTM) | 29.92 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 86.96 |
| Operating Margin(TTM) % | 38.86 |
| Profit Margin(TTM) % | 41.61 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
